Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | State-of-the-art liquid biopsy facility at the Royal Marsden

Michael Hubank • 17 Oct 2021

Michael Hubank, PhD, The Royal Marsden NHS Foundation Trust, London, UK, discusses the in-house liquid biopsy testing facility that is currently being developed at the Royal Marsden Hospital in London. The Royal Marsden has partnered with Guardant Health for this project, with the aim of delivering comprehensive in-house testing to improve both clinical diagnostics for patients and the development of clinical trials. Prof. Hubank expects the facility to be operational within 6-9 months and hopes that successful operation of the facility will provide a strong argument for expanding liquid biopsy testing across the NHS.

Disclosures

Prof. Hubank has received personal or laboratory financial support received for talks and/or advisory boards from Guardant Health, and also from Amgen, Astex Pharmaceuticals, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Lilly, Illumina, Incyte, Merck, Novartis, Qiagen, Roche Diagnostics.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.